Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients With Synchronous Brain Metastases

Scientific Reports- United Kingdom

doi 10.1038/s41598-019-54513-3

Full Text

Abstract

Available in

Categories

Multidisciplinary

Date

November 28, 2019

Authors

Mustafa S. Ascha

Jacqueline Fang Wang

Priya Kumthekar

Andrew E. Sloan

Jill S. Barnholtz-Sloan

Publisher

Springer Science and Business Media LLC

Related search

Cases of Non-Small Cell Lung Cancer With Brain Metastases Treated With Bevacizumab in Our Hospital

Japanese Journal of Lung Cancer

Respiratory Medicine

English

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

Clinical Oncology

Nuclear Medicine

English

Therapeutic Strategy for Non‑small‑cell Lung Cancer Patients With Brain Metastases (Review)

Biomedical Reports

Molecular Biology

English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Cancer Research

Molecular Biology

English

Non-Small Cell Lung Cancer Brain Metastases and the Immune System: From Brain Metastases Development to Treatment

Cancer Treatment Reviews

Nuclear Medicine

English

S100B as a Biomarker for Brain Metastases in Patients With Non‑small Cell Lung Cancer

Biomedical Reports

Molecular Biology

English

Preface on “Emerging Treatment Options for Brain Metastases From Non-Small Cell Lung Cancer”

Translational Lung Cancer Research

English

Efficacy of Chemotherapy in Patients With Asymptomatic Brain Metastases From Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer

Respiratory Medicine

English

18f-Fet PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non–Small Cell Lung Cancer

Clinical Nuclear Medicine

Nuclear Medicine

English